Saturday, October 8, 2011

HEALING OF PARKINSON'S DISEASE THRU MEDICINE (ANTICHOLINERGICS)


      The mechanism of action of anticholinergics is believed be involved in correcting the disequilibrium between striatal dopamine and acetylcholine neurotransmission. Some anticholinergics, e.g. benzotropine, can also block dopamine uptake in central dopaminergic neurons. The anticholinergics used to treat PD specifically block muscarinic receptors. These drugs have only a small effect on PD symptoms, and that evidence for a special effect on tremor is inconclusive. Because of the risk of side effects, centrally acting anticholinergics are usually not advised for the therapy of non - motor, i.e. autonomic, dysfunctions.
    
 The clinical use of anticholinergics has been limited by their side- effect profiles and contraindications. The most commonly reported side effects are blurred vision,urinary retention, nausea, constipation (rarely leading to paralytic ileus), and dry mouth. The incidence of reduced sweating, particularly in those patients on neuroleptics, can lead to fatal heat stroke.
    
 Anticholinergics are contraindicated in patients with narrow-angle glaucoma, tachycardia, hypertrophy of the prostate, gastrointestinal obstruction, and   megacolon. Impaired mental function (mainly immediate memory and  memory acquisition) and acute confusional state are a well documented central side effect that resolves after drug withdrawal. Therefore, if dementia is present, the use of anticholinergics is contraindicated. The abrupt withdrawal of anticholinergics may lead to a rebound effect with marked deterioration of parkinsonism. Consequently, anticholinergics should be discontinued gradually and with caution.

      An anticholinergic preparation  which is commercially available in the Philippines is biperiden Hcl. The brand names of Biperiden HCl are (AKINETON) by ABBOTT,  (AKIDIN) by MED CHOICE PHARMA and (AKETON) by YOO YOUNG. The indications, dosage, manner of administration, contraindications, special precautions, adverse reactions and drug interactions are as follows:


INDICATIONS:   TAB: Adjunct therapy of all forms of parkinsonism (post-encephalitic, arteriosclerotic and idiopathic)
   AMP: Symptomatic treatment of parkinsonism including the alleviation of the extrapyramidal syndrome induced by drugs

DOSAGE:    TAB: Adult Parkinsonism : Initially 1 mg BID, increased by 2 mg/day. Maximum: 16 mg daily
        Drug-induced movement disorders : 1-4 mg once-QID
        Children : 3-15 yr 1-2 mg once-TID

ADMINISTRATION: May be taken with or without food

CONTRAINDICATIONS:     Untreated narrow-angle glaucoma
     Intestinal stenoses or obstruction
     Megacolon
     Prostatic hypertrophy
     Life-threatening tachycardia

SPECIAL PRECAUTIONS:
     Avoid abrupt discontinuation.
     Increased sensitivity to side effects especially elderly.
     Enhanced risk of cerebral seizures in predisposed persons.
     Abuse
     Impaired ability to drive or operate machinery.

ADVERSE REACTIONS:     Fatigue
     Dizziness
     Drowsiness
     Dry mouth
     Rarely : Swelling of salivary glands
              Accommodation difficulties
              Mydriasis
              Photophobia
              Hypohydrosis
              Constipation
              Gastric symptoms
              Nausea
              Tachycardia
     Very rarely: Bradycardia, especially at higher doses
              Restlessness
              Agitation
              Anxiety
              Confusion
              Euphoria
     Occasionally: Impairment of memory
     In rare cases: Delirium
              Hallucinations
              Nervousness
              Headache
              Insomnia
              Dyskinesia
              Ataxia
              Muscle twitching
              Speech Impairment

DRUG INTERACTIONS:    Enhanced anticholinergic effects in combination with other psychotropic drugs
    Antihistamines
    Antiparkinsonism drugs
    Antispasmodics
    Quinidine
    Pethidine
    Dyskinesia induced by levodopa may be potentiated
    Effects of alcohol may be enhanced
    Antagonistic influence on the action of metoclopramide and compound of similar activity in the GIT.

    To get an update in the diagnosis and management of Parkinson's disease, Pinoy Parkinson's Disease or Pinoy PD is holding its First Annual Convention on October 22, 2011 in Makati City.


P.S. EXTENDED FREE REGISTRATION! Register for FREE on or before OCTOBER 15, 2011.


P.P.S. Register for a GUARANTEED SEAT and SLOT in the workshop to a LIMITED NUMBER of participants on or before OCTOBER 15, 2011 including LUNCH, 2 SNACKS and SEMINAR KIT.


P.P.P.S. Submit REGISTRATION DETAILS (Name, Age, Contact number and E-mail address) on or before OCTOBER 15, 2011 to avail of FREE REGISTRATION and send via email to drajoy31@yahoo.com / drajoy31@gmail.com


   

1 comment:



  1. My husband was diagnosed with early onset Parkinson's disease at 57.his symptoms were shuffling of feet,slurred speech, low volume speech, degradation of hand writing, horrible driving skills, right arm held at 45 degree angle, things were tough for me, but now he finally free from the disease with the help of total cure ultimate health home, he now walks properly and all symptoms has reversed, he had trouble with balance especially at night, getting into the shower and exiting it is difficult,getting into bed is also another thing he finds impossible.we had to find a better solution for his condition which has really helped him a lot,the biggest helped we had was ultimatehealthhome they walked us through the proper steps,am highly recommended this ultimatehealthhome@gmail.com to anyone who needs help.

    ReplyDelete